Terms: = Lung cancer AND CDH11, OB, 1009, ENSG00000140937, CAD11, P55287 AND Treatment
21 results:
1. Characterization of Viscum album L. Effect on Immune Escape Proteins PD-L1, PD-L2, and MHC-I in the Prostate, Colon, lung, and Breast cancer Cells.
Devi S; Gründemann C; Huber R; Kowarschik S
Complement Med Res; 2023; 30(5):386-392. PubMed ID: 36927644
[TBL] [Abstract] [Full Text] [Related]
2. The potential bioactive ingredients and hub genes of five TCM prescriptions against lung adenocarcinoma were explored based on bioinformatics.
Liu T; Wei J
Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):2039-2055. PubMed ID: 36914901
[TBL] [Abstract] [Full Text] [Related]
3. Pulmonary delivery of osimertinib liposomes for non-small cell lung cancer treatment: formulation development and in vitro evaluation.
Sawant SS; Patil SM; Shukla SK; Kulkarni NS; Gupta V; Kunda NK
Drug Deliv Transl Res; 2022 Oct; 12(10):2474-2487. PubMed ID: 34816394
[TBL] [Abstract] [Full Text] [Related]
4. Neutrophil-Lymphocyte Ratio and Absolute Lymphocyte Count as Prognostic Markers in Patients Treated with Curative-intent Radiotherapy for Non-small Cell lung cancer.
Punjabi A; Barrett E; Cheng A; Mulla A; Walls G; Johnston D; McAleese J; Moore K; Hicks J; Blyth K; Denholm M; Magee L; Gilligan D; Silverman S; Qureshi M; Clinch H; Hatton M; Philipps L; Brown S; O'Brien M; McDonald F; Faivre-Finn C; Hiley C; Evison M
Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):e331-e338. PubMed ID: 33863615
[TBL] [Abstract] [Full Text] [Related]
5. End-of-life cost for lung cancer patients in Greece: a hospital-based retrospective study.
Kokkotou E; Stefanou G; Syrigos N; Gourzoulidis G; Ntalakou E; Apostolopoulou A; Charpidou A; Kourlaba G
J Comp Eff Res; 2021 Mar; 10(4):315-324. PubMed ID: 33605788
[No Abstract] [Full Text] [Related]
6. A Network Pharmacology Approach to Explore the Potential Mechanisms of Huangqin-Baishao Herb Pair in treatment of cancer.
Xu T; Wang Q; Liu M
Med Sci Monit; 2020 Jul; 26():e923199. PubMed ID: 32609659
[TBL] [Abstract] [Full Text] [Related]
7. [TCM Combined Western Medicine treatment of Advanced NSCLC: a Preliminary Study of mIRNA Expression Profiles].
Li YB; Lin LZ; Guan JS; Chen CM; Zuo Q; Lin BQ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Sep; 36(9):1076-1081. PubMed ID: 30645846
[TBL] [Abstract] [Full Text] [Related]
8. Differential Expression Pattern of THBS1 and THBS2 in lung cancer: Clinical Outcome and a Systematic-Analysis of Microarray Databases.
Weng TY; Wang CY; Hung YH; Chen WC; Chen YL; Lai MD
PLoS One; 2016; 11(8):e0161007. PubMed ID: 27513329
[TBL] [Abstract] [Full Text] [Related]
9. Dacomitinib in lung cancer: a "lost generation" EGFR tyrosine-kinase inhibitor from a bygone era?
Ou SH; Soo RA
Drug Des Devel Ther; 2015; 9():5641-53. PubMed ID: 26508839
[TBL] [Abstract] [Full Text] [Related]
10. (1) H NMR spectroscopy of glioblastoma stem-like cells identifies alpha-aminoadipate as a marker of tumor aggressiveness.
Rosi A; Ricci-Vitiani L; Biffoni M; Grande S; Luciani AM; Palma A; Runci D; Cappellari M; De Maria R; Guidoni L; Pallini R; Viti V
NMR Biomed; 2015 Mar; 28(3):317-26. PubMed ID: 25581615
[TBL] [Abstract] [Full Text] [Related]
11. Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial.
Carson JL; Sieber F; Cook DR; Hoover DR; Noveck H; Chaitman BR; Fleisher L; Beaupre L; Macaulay W; Rhoads GG; Paris B; Zagorin A; Sanders DW; Zakriya KJ; Magaziner J
Lancet; 2015 Mar; 385(9974):1183-9. PubMed ID: 25499165
[TBL] [Abstract] [Full Text] [Related]
12. Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial.
Ramalingam SS; Jänne PA; Mok T; O'Byrne K; Boyer MJ; Von Pawel J; Pluzanski A; Shtivelband M; Docampo LI; Bennouna J; Zhang H; Liang JQ; Doherty JP; Taylor I; Mather CB; Goldberg Z; O'Connell J; Paz-Ares L
Lancet Oncol; 2014 Nov; 15(12):1369-78. PubMed ID: 25439691
[TBL] [Abstract] [Full Text] [Related]
13. Identification of a meiosis-specific protein, MEIOB, as a novel cancer/testis antigen and its augmented expression in demethylated cancer cells.
Shiohama Y; Ohtake J; Ohkuri T; Noguchi D; Togashi Y; Kitamura H; Nishimura T
Immunol Lett; 2014; 158(1-2):175-82. PubMed ID: 24440806
[TBL] [Abstract] [Full Text] [Related]
14. [Research advances on leptin and respiratory diseases].
Chai SB; Wang J; Tang CS
Sheng Li Ke Xue Jin Zhan; 2013 Apr; 44(2):81-6. PubMed ID: 23847916
[TBL] [Abstract] [Full Text] [Related]
15. Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small-cell lung cancer.
Spigel DR; Anthony Greco F; Waterhouse DM; Shipley DL; Zubkus JD; Bury MJ; Webb CD; Hart LL; Gian VG; Infante JR; Burris HA; Hainsworth JD
Lung Cancer; 2012 Oct; 78(1):70-5. PubMed ID: 22947511
[TBL] [Abstract] [Full Text] [Related]
16. Patient survival and safety with biologic therapy. Results of the Mexican National Registry Biobadamex 1.0.
Ventura-Ríos L; Bañuelos-Ramírez D; Hernández-Quiroz Mdel C; Robles-San Román M; Irazoque-Palazuelos F; Goycochea-Robles MV
Reumatol Clin; 2012; 8(4):189-94. PubMed ID: 22673388
[TBL] [Abstract] [Full Text] [Related]
17. Phase II study of maintenance sunitinib following irinotecan and carboplatin as first-line treatment for patients with extensive-stage small-cell lung cancer.
Spigel DR; Greco FA; Rubin MS; Shipley D; Thompson DS; Lubiner ET; Eakle JF; Quinn R; Burris HA; Hainsworth JD
Lung Cancer; 2012 Aug; 77(2):359-64. PubMed ID: 22560921
[TBL] [Abstract] [Full Text] [Related]
18. Reliability of adverse symptom event reporting by clinicians.
Atkinson TM; Li Y; Coffey CW; Sit L; Shaw M; Lavene D; Bennett AV; Fruscione M; Rogak L; Hay J; Gönen M; Schrag D; Basch E
Qual Life Res; 2012 Sep; 21(7):1159-64. PubMed ID: 21984468
[TBL] [Abstract] [Full Text] [Related]
19. Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel.
Barriger RB; Fakiris AJ; Hanna N; Yu M; Mantravadi P; McGarry RC
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1381-6. PubMed ID: 20231061
[TBL] [Abstract] [Full Text] [Related]
20. [Nude mouse model of human gastric carcinoma metastasis constructed by orthotopic transplantation using organism glue paste technique].
Chen YL; Wei PK; Xu L; Su XM
Ai Zheng; 2005 Feb; 24(2):246-8. PubMed ID: 15694045
[TBL] [Abstract] [Full Text] [Related]
[Next]
